No Detail Found!

Specific Immune Marker Associated With Coronavirus Disease 2019

Author(s)
Zainab Fayadh Shubrem Institute of Genetic Engineering for Post graduate Study ,University of Baghdad,,
Wathiq Abbass Institute of Genetic Engineering for Post graduate Study ,University of Baghdad,,
Abstract
Background: The infection that caused the pneumonia, the virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the source of coronavirus disease 2019 (COVID-19) is the source of the global pandemic. The pneumonia cases began in Wuhan, China in December 2019 and had no apparent reason. Essential inflammatory mediators Chemokines are necessary for an immune response to eliminate pathogens. However, the fundamental cause of hyper inflammation is their excessive release. Chemokines may be directly responsible for the acute respiratory illness syndrome in the current COVID-19 outbreak. Objective: The current study aimed to estimate hematological changes with immunogenic markers CD177, GNLY, and CXCR4 gene expression in COVID-19 patients, and compare these parameters among patients and healthy individuals. Materials and Methods: the study was conducted at Al- Yarmouk Teaching Hospital and Medical Teaching Laboratories. Finally, to detect the immune markers level in samples of patients, by RT-PCR. Results: the results revealed the gene expression results in patients with COVID-19 means Ct difference of CD177 (24.70) fold more than (10.5) elevated when compared with the mean of Ct control healthy group is (28.21) fold of gene expression is 1.00 of CD177 when our study showed increased gene expression the mean of GNLY Ct receptor was reached to (28.70 ng/L) with fold more than 15.0 in COVID-19 patients, while mean Ct in healthy control was (32.61 ng/L) with fold 1.00, the current study found mean CT of CXCR4 gene expression ( 31.2) with fold (1.1) compared with healthy control CT(31.3) fold of gene expression was (1.0). Conclusion: It was concluded that COVID-19 caused significant changes in many immunological parameters and found the titer of immune markers was higher in infection compared with control.
Publication Details
Page(s) 137-143
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
COVID19, CD177, VTM, CXCR4, RT PCR, GNLY
References
Farah H.,Ali I. A. .2023 .Molecular Detection of Candida spp. Isolated from Female Patients Infected with COVID-19 in Baghdad City. Iraqi Journal of Biotechnology, 22(1) : 238-244.
AL A. D. A. A. N. .2022 .Determination of Angiotensin-Converting Enzyme 2 (ACE2) Receptor Level in Samples of Iraqi Patients Infected with COVID-19. Iraqi Journal of Biotechnology, 21(2) : 178-182.
Shehab E. N. K. Z. H. .2022 .Rapid Identification of some typical and atypical Pneumonia co-infections associated with COVID-19 patients by a real-time PCR assay. Iraqi Journal of Biotechnology, 21(2) : 331-340.
AL F. M. M. A. N.,Jiad T. K. S. .2022 .Interleukin-1 Beta (IL-1β ) Persistence in Post SARS-CoV-2 Infection and Vaccination: A Double Case Control Study. Iraqi journal of biotechnology, 21(2) : 561-567.
Khalil B. A.,Elemam N. M.,Maghazachi A. A. .2021 .Chemokines and chemokine receptors during COVID-19 infection. Computational and Structural Biotechnology Journal, 19 : 976-988.
Lévy Y.,Wiedemann A.,Hejblum B. P.,Durand M.,Lefebvre C.,Surénaud M.,Thiébaut R. .2021 .CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death. Iscience, 24(7) : 102711.
Ramljak D.,Vukoja M.,Curlin M.,Vukojevic K.,Barbaric M.,Glamoclija U.,Soljic V. .2021 .Early response of CD8+ T cells in COVID19 patients. Journal of Personalized Medicine, 11(12) : 1291.
Schmittgen T. D.,Livak K. J. .2008 .Analyzing real-time PCR data by the comparative CT method. Nature Protocols, 3(6) : 1101-1108.
Mankhey F. A.,Alattabi A. S.,Hamza D. M. .2021 .Correlation of Immunological Markers Levels (Il-2rα , Cd107a & Fasl) With the Severity of Covid-. Patients. Biochemical & Cellular Archives, 21(2) : .
Gómez-Belda A. B.,Fernández-Garcés M.,Mateo-Sanchis E.,Madrazo M.,Carmona M.,Piles-Roger L.,Artero A. .2021 .COVID-19 in older adults: What are the differences with younger patients?. Geriatrics & Gerontology International, 21(1) : 60-65.
Guan W. J.,Ni Z. Y.,Hu Y.,Liang W. H.,Ou C. Q.,He J. X.,Zhong N. S. .2020 .Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18) : 1708-1720.
Alsan M.,Stantcheva S.,Yang D.,Cutler D. .2020 .Disparities in coronavirus 2019 reported incidence, knowledge, and behavior among US adults. Jama Network Open, 3(6) : e2012403-e2012403.
Shim E.,Tariq A.,Choi W.,Lee Y.,Chowell G. .2020 .Transmission potential and severity of COVID-. International Journal of Infectious Diseases, 93 : 339-344.
Aschenbrenner A. C.,Mouktaroudi M.,Krämer B.,Oestreich M.,Antonakos N.,Nuesch-Germano M.,Ulas T. .2021 .Disease severityspecific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Medicine, 13 : 1-25.
Bayat B.,Werth S.,Sachs S.,Newman D. K.,Newman P. J.,Santoso S. .2010 .Neutrophil transmigration mediated by the neutrophilspecific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. The Journal of Immunology, 184(7) : 3889-3896.
Demaret J.,Venet F.,Plassais J.,Cazalis M. A.,Vallin H.,Friggeri A.,Monneret G. .2016 .Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patients. Immunology Letters, 178 : 122-130.
Fu J.,Kong J.,Wang W.,Wu M.,Yao L.,Wang Z.,Yu X. .2020 .The clinical implication of dynamic neutrophil to lymphocyte ratio and Ddimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Research, 192 : 3-8.
Tang B. M.,Shojaei M.,Teoh S.,Meyers A.,Ho J.,Ball T. B.,Schughart K. .2019 .Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection. Nature Communications, 10(1) : 3422.
Huang C.,Huang L.,Wang Y.,Li X.,Ren L.,Gu X.,Cao B. .2023 .6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 401(10393) : e21-e33.
Toubiana J.,Poirault C.,Corsia A.,Bajolle F.,Fourgeaud J.,Angoulvant F.,Allali S. .2020 .Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational. , : 05.
Viner R. M.,Whittaker E. .2020 .Kawasaki-like disease: emerging complication during the COVID-19 pandemic. The Lancet, 395(10239) : 1741-1743.
Jing Y.,Ding M.,Fu J.,Xiao Y.,Chen X.,Zhang Q. .2020 .Neutrophil extracellular trap from Kawasaki disease alter the biologic responses of PBMC. Bioscience Reports, 40(9) : BSR20200928.
Ko T. M.,Chang J. S.,Chen S. P.,Liu Y. M.,Chang C. J.,Tsai F. J.,Wu J. Y. .2019 .Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease. Scientific Reports, 9(1) : 328.
Brandes M.,Klauschen F.,Kuchen S.,Germain R. N. .2013 .A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell, 154(1) : 197-212.
Narasaraju T.,Yang E.,Samy R. P.,Ng H. H.,Poh W. P.,Liew A. A.,Chow V. T. .2011 .Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. The American Journal of Pathology, 179(1) : 199-210.
Zaas A. K.,Chen M.,Varkey J.,Veldman T.,Hero A. O.,Lucas J.,Ginsburg G. S. .2009 .Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host & Microbe, 6(3) : 207-217.
Ahmadi P.,Hartjen P.,Kohsar M.,Kummer S.,Schmiedel S.,Bockmann J. H.,Schulze zur Wiesch J. .2020 .Defining the CD39/CD73 axis in SARS-CoV-2 infection: the CD73-phenotype identifies polyfunctional cytotoxic lymphocytes. Cells, 9(8) : 1750.
Mazzoni A.,Salvati L.,Maggi L.,Capone M.,Vanni A.,Spinicci M.,Cosmi L. .2020 .Impaired immune cell cytotoxicity in severe COVID19 is IL-6 dependent. The Journal of clinical investigation, 130(9) : 4694-4703.
Li M.,Guo W.,Dong Y.,Wang X.,Dai D.,Liu X.,Hu D. .2020 .Elevated exhaustion levels of NK and CD8+ T cells as indicators for progression and prognosis of COVID-19 disease. , 11 : 580237.
Jiang Y.,Wei X.,Guan J.,Qin S.,Wang Z.,Lu H.,Lin X. .2020 .COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential. Clinical Immunology, 218 : 108516.
Bellesi S.,Metafuni E.,Hohaus S.,Maiolo E.,Marchionni F.,D'Innocenzo S.,De Stefano V. .2020 .Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. British Journal of Haematology, 191(2) : 207-211.
Sansico F.,Miroballo M.,Bianco D. S.,Tamiro F.,Colucci M.,Santis E. D.,CSS-COVID E. D. .2021 .COVID-19 specific immune markers revealed by single cell phenotypic profiling. Biomedicines, 9(12) : 1794.
Daoud S.,Taha M. .2022 .Ligand-based modeling of CXC chemokine receptor 4 and identification of inhibitors of novel chemotypes as potential leads towards new anti-COVID-19 treatments. Medicinal Chemistry, 18(8) : 871-883.
Bianchi M. E.,Mezzapelle R. .2020 .The chemokine receptor CXCR4 in cell proliferation and tissue regeneration. Frontiers in Immunology, 11 : 560971.
HASSAN S. M.,AL-JAF A. N. A.,HUSSIEN Y. A.,AWAD S. M.,ABDULKHALEQ S. M.,HADI M. A.,N. R. M. A. .2020 .Effect of new synthesized compounds of 2-Thiouracil Sulfonamide Derivatives against colon and liver carcinoma cells “In Vitro Study. International Journal of Pharmaceutical Research, 12(4) : 2012-6.
Hassan S. M.,Obeid H. A.,Hasan I. S.,Abbas A. N. .2023 .Etanercept ameliorated cerebral damage during global cerebral ischemiareperfusion injury in male rats. Azerbaijan Pharmaceutical and Pharmacotherapy Journal, 22(1) : 53-58.
0

Citations

0

Downloads

27

Views